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Abstract
Background: Urinary incontinence (UI) is a newly recognised problem in cystic fibrosis. Whilst prevalence is well documented,
there are no reports of assessment and treatment of the problem. Methods: A previous study reports the prevalence of UI in
women with CF to be 51y75 (68%). Nineteen women subsequently requested help for the problem and were referred to a
physiotherapist specialising in women’s health. A digital assessment was performed to measure pelvic floor muscle strength and
endurance. An individualised programme of pelvic floor muscle exercises (PFME) was taught based on the assessment. A
questionnaire addressed issues of assessment and treatment. Results: 12 women were assessed. The median (range) age, FEV1%
predicted and BMI were 20.9 (19.3–46.1) years, 45.9 (14.8–82.7) and 20.5 (16.1–26.0), respectively. The median strength of
the pelvic floor muscle was moderate (Oxford Scale grade 3) with a hold time (endurance) of 5 s. At reassessment (median time
13.1 weeks), there was an improvement in endurance (Ps0.04), with no change in strength. This was supported by a subjective
improvement in symptoms. Patients found the exercises were difficult to perform, difficult to fit into their treatment programme
and adherence was poor. Conclusions: PFME are effective at improving endurance and reducing leakage over the short-term.
Women are reluctant to be assessed and the CF team should provide support and encouragement with treatment. Long-term
outcome and the mechanisms of UI in this group of patients need further evaluation.
 2003 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Leakage of urine is now a recognised problem in
women with cystic fibrosis (CF). Cornacchia et al. and
White et al. reported a prevalence of 59% and 37.9%,
respectively w1,2x. From a questionnaire survey, we
recently reported a prevalence of urinary incontinence
(UI) in women with CF to be 68% w3x. Whilst there are
several reports of the prevalence of UI in CF there are
no studies of the assessment and treatment of the
problem.
Pelvic floor muscle exercises (PFME) have been well
described in the literature as an effective form of
treatment for urinary incontinence in the general popu-
lation. A systematic review of randomised controlled
trials showed strong evidence that PFME reduced symp-
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toms of genuine stress incontinence w4x and when
compared to electrical stimulation, vaginal cones and no
treatment improved muscle strength and reduced leakage
w5x.
The aim of this study was to report the assessment
and treatment of women who requested help for their
UI using pelvic floor muscle exercises.
2. Methods
A previous study found the prevalence of urinary
incontinence, defined as leakage of urine occurring more
than once or twice in the previous 12 months to be
68%. The severity of leakage ranged from ‘a few drops’
(61%) to ‘leakage through to overclothes’ (10%), and
29% of women said they were ‘severely distressed by
the problem’. Nineteen women (37%) requested help
for the problem w3x.
The assessment procedure was discussed with each
woman who had requested help by a CF physiotherapist
(MD, RM, AO), either at a clinic visit or during a
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Table 1
Modified Oxford muscle grading scheme (Laycock, 2001)
Grading Muscle response Description
0 Nil No discernible muscle contraction
1 Flicker A flicker or pulse is felt under the examiners finger
2 Weak An increase in tension is detected, without any discernible lift
3 Moderate Muscle tension is further enhanced and characterised by lifting of the
muscle belly and also elevation of the posterior vaginal wall
4 Good Increased tension and a good contraction are present which are capable
of elevating the posterior vaginal wall against resistance
5 Strong Strong resistance can be applied to the elevation of the posterior vaginal
wall; the examiners fingers are squeezed and drawn into the vagina
hospital admission. As our patients are referred from a
wide geographical area in the North West of England,
we felt it was important to offer them the choice of
treatment by either their local hospital or by the hospital
to which the CF Centre is attached. All women
expressed a preference to be seen at the hospital to
which the CF Centre is attached. It was explained that
they would be referred to an experienced physiotherapist
specialising in women’s health problems (AB, LK, EP)
and that during the assessment, the pelvic floor muscle
would be examined. Referral was verbal and each
woman was contacted to arrange an appointment time
convenient to her.
The initial appointment involved digital assessment
of pelvic floor muscle strength using the modified
Oxford grading scale (Table 1), endurance of pelvic
floor muscle contraction (as measured by hold time)
and the number of repetitions of each contraction that
could be performed w6x. Patients were also questioned
about obstetric history, menopausal state and the use of
pads. Frequency–volume charts were issued at the dis-
cretion of the physiotherapist.
Based on the strength, endurance and number of
repetitions each patient could perform during the assess-
ment, the physiotherapist prescribed an individualised
programme of pelvic floor muscle exercises (PFME)
following the general muscle training principles of
overload and specificity. The aim of the pelvic floor
muscle exercise programme was for each woman to
hold her strongest contraction as long as possible and
to repeat as many times to the point of fatigue. The aim
then being to increase the number of repetitions and
hold time to be able to perform 10 repetitions of a 10 s
contraction at regular intervals throughout the day w6x.
Several sessions of exercise were encouraged on a daily
basis w6x. PFME were the treatment of choice as they
have been shown to be effective in treating UI in other
patient groups and are recommended for women with
muscle strength of grade 3, 4 or 5 w4,5,7x. Patients were
offered further follow-up sessions to monitor their pro-
gress with the exercises and reassessment of the pelvic
floor were performed by the same physiotherapist based
upon subjective improvement in leakage. In most cases,
5 follow-up sessions were offered over a 3-month period
but this was extended for some patients who had
difficulty with progression of their exercises due to
respiratory exacerbation.
All patients were given advice about fluid intake and
caffeine-containing drinks that act as a diuretic.
Demographic data were collected together with the
number of appointments, number of appointments
missed or cancelled and the number of respiratory
exacerbation days w8x within the treatment period.
As this was the first time women had been referred
for treatment of UI in our Centre, a questionnaire was
designed to address some of the issues that may be
faced by them. (Appendix A). The questionnaire was
self-administered and issued at the end of the treatment
period. The women were asked to rate their level of
agreement with 12 statements on a 6 point Likert scale.
The responses ranged from ‘strongly agree’ to ‘strongly
disagree’, which have been condensed into larger cate-
gories for the purpose of analysis. The first section of
the questionnaire was completed by all the women who
requested help and contained three questions about the
severity of incontinence, its impact on the patients’
lives, and their feelings about being assessed for the
problem. The second section contained questions about
the assessment procedure and treatment issues, and was
completed only by those patients who went on to be
assessed.
3. Analysis
The Mann–Whitney test was used for analysis of all
variables.
4. Results
Nineteen women requested help for their urinary
incontinence. Of the 19 women, 4 had previously had a
pregnancy but only 1 went on to be assessed and this
patient had suffered from incontinence prior to her
pregnancy. None of the women were menopausal. A
total of 12y19 was assessed. Of the remaining 7, 1
immediately decided against assessment once this had
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Table 2
Baseline characteristics of women who were assessed and those who
declined
Assessed Declined P
ns12 ns7
Age (years) 20.9 (19.3–46.1) 30.9 (17.9–39.2) ns
FEV1% predicted 45.9 (14.8–82.7) 56.1 (19.4–81.9) ns
BMI (wtyht )2 20.5 (16.1–26.0) 21.3 (19.4–22.0) ns
Values expressed as median (range).
Table 3
Muscle strength, endurance and number of repetitions at baseline and
reassessment
Baseline Reassessment P
ns12 ns10
Oxford grade 3 (2–4) 3 (2–4) ns
Hold time (s) 5 (3–30) 7 (5–76) 0.04
Repetitions 4 (3–5) 5 (4–10) ns
Values expressed as median (range).
Fig. 1. Responses of women (ns11) to questions following assessment and treatment of the pelvic floor. Agreed j; disagreedZ.
been discussed, 5 decided to take time to think about it
and did not change their minds during the 9 month
study period and 1 patient failed to attend her appoint-
ment. There was no difference in age, FEV1% predicted
and BMI for the women who were assessed and those
who declined (Table 2).
At assessment, the strength of the pelvic floor muscle,
as measured by the Oxford grading scale was 3, (2–4)
(median, range). 10y12 patients attended follow-up
appointments over a 9-month period and were reassessed
at a median of 13.1 weeks, (range 3–35.7). There was
no improvement in muscle strength at reassessment.
However, there was an improvement in endurance, as
measured by hold time (Ps0.04). There was no change
in the number of repetitions that could be performed
(Table 3).
The median (range) number of attendance’s was 2.5
(1–6). More than half of appointments made were
cancelled or missed (26y43). The median number of
days spent in respiratory exacerbation over the treatment
period was 21 (range 0–223).
Frequency–volume charts were completed by 4y12
women. These showed increased frequency of micturi-
tion, small volumes being voided, poor fluid intake and
substantial consumption of drinks containing caffeine.
Pads were used by 8y12 women. 5y8 used pads inap-
propriate for urinary incontinence.
The first section of the ‘issues’ questionnaire was
completed by 17y19 women; 1 woman refused and 1
did not attend the CF clinic during the period that the
questionnaires were being administered. 15y17 patients
agreed that leakage was a big problem and 10y17 agreed
that leakage greatly interfered with their lives. 11y17
strongly agreedyagreed that they felt happy about being
assessed. 3y17 slightly disagreed and commented that
they ‘felt uncomfortable with the thought of assessment’,
‘didn’t like the idea of an internal examination’ and
‘were embarrassed’.
The second section of the questionnaire was complet-
ed by 11 of the 12 women who went on to be assessed.
One woman who had been assessed did not complete
the questionnaire because she did not attend the CF
clinic during the time period that the questionnaires
were being issued. 9y11 agreed they felt happy with the
assessment procedure but 2y11 disagreed because they
‘found the internal uncomfortable’ (Fig. 1). All felt they
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understood the action of the pelvic floor muscle follow-
ing the assessment. 5y11 found the pelvic floor exercises
difficult to do with comments of ‘hard to remember to
do them’, ‘ felt tired out and took a lot of time’ and
‘felt breathless’. In addition, they found the exercises
difficult to fit into their home treatment programme and
did not do them as often as advised. Leakage improved
for 7y11 despite poor attendance at appointments. In
the remaining 4y11, leakage had become worse because
of ‘constant chest problems’ or had remained the same.
10y11 women agreed that the advice and treatment had
been worthwhile. One commented that leakage had
improved following a liver transplant and was unrelated
to the advice and treatment.
5. Discussion
Urinary incontinence is a newly recognized problem
in cystic fibrosis with a higher prevalence than in the
general population of women of a similar age, w2,3x. It
has a negative impact on quality of life and for some,
when it affects ability to carry out airway clearance or
perform routine spirometric measurement, it may also
have a clinical impact on the assessment and manage-
ment of CF lung disease w3x. An understanding of the
mechanisms of incontinence is essential to the manage-
ment of the problem.
In our study, the median strength of the pelvic floor
muscle was 3, which is described as a moderate con-
traction in the modified Oxford grading scheme (Table
1). The endurance (hold time) of the contraction was 5
s and the median number of repetitions of each timed
contraction was 4. At reassessment the endurance of the
pelvic floor had improved significantly although strength
remained unchanged. In addition, most women reported
a subjective improvement in leakage. These findings are
in agreement with Hahn et al., who reported a similar
number of women demonstrating subjective improve-
ment in symptoms but no significant improvement in
muscle strength w9x.
Several women commented that leakage became
worse because of constant exacerbations, which were
felt to hamper progress with pelvic floor exercises.
Chronic cough is considered to be a poor prognostic
indicator for the success of treatment of UI w10x. The
continuous insult of coughing on the pelvic floor would
suggest that PFME would probably need to be continued
life-long in this group of patients. A maintenance exer-
cise programme is recommended w7x but success of
treatment is dependent on motivation and adherence to
exercise w11x.
Whilst ‘forgetting to do’ PFME is common w12,13x,
our group of patients have the additional burden of a
multisystem disease and found the exercises difficult to
fit into their already extensive home treatment pro-
gramme which can occupy up to 3 h per day w14x.
Although most of the women felt UI was a big problem
that greatly interfered with their lives, it may be that
they perceive treatment of this problem to be a low
priority in comparison to other aspects of their illness.
Bo w15x found that motivation and adherence were
improved by regular treatment sessions and contact with
the therapist. Appointments were poorly attended by our
group. More than half of appointments made were
cancelled or missed despite best efforts by the physioth-
erapist to arrange them to coincide with outpatient clinic
visits to the CF Centre. The women may have been
deterred from attending appointments at two different
locations albeit at the same hospital. Harrison and
Memel also reported poor attendance at appointments
for incontinence. Out of 167 appointments made for
women with UI, only 13 were attended w16x. Patients
may be more likely to attend appointments if the
specialist physiotherapist is present at the routine CF
clinic. Currently, arrangements have been made for this
to occur in our unit.
Despite the high prevalence of UI in women with CF,
the number seeking help is small. The severity of the
leakage in our group varies from a few drops to leakage
through to overclothes and only 29% of women said
they were severely distressed by the problem. Thirty
seven percentage of women asked for help with the
problem and Cornacchia et al. report similar numbers
w1x. It may be that the majority of women see the
problem as relatively mild and low priority in relation
to other aspects of their disease. Even women who
requested help for the problem were reluctant to be
assessed by a specialist physiotherapist because of
embarrassment and apprehension about the assessment
process. Embarrassment is also seen as a barrier to
discussion about other aspects of sexual and reproduc-
tive health between patients with cystic fibrosis and
their health professionals w17x. Health professionals
should be aware of the need to initiate discussion about
potentially embarrassing subjects w18x. A questionnaire
survey of women during pregnancy and childbirth by
Mason et al. commented that women wanted health
professionals to be proactive in seeking out information
about symptoms rather than having to broach the subject
themselves w19x. In our unit, women are now questioned
routinely at annual assessment about symptoms.
Many of the women had used pads at some time to
protect from leakage and it has been suggested that this
may be a way of concealing the problem, rather than
seeking medical help w20x. Questioning about the use of
pads should form part of the assessment as some sanitary
protection is inappropriate for leakage of urine and may
contribute to skin irritation.
We have shown that the endurance of the pelvic floor
muscle can be improved with PFME in adult women
with CF. The numbers in our study are small and whilst
improvement in symptoms was demonstrated over the
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short-term, long-term outcome of PFME needs to be
evaluated in this group of patients. The mechanism of
UI in CF is not fully understood and further studies are
required to improve clinical outcome for this group of
patients. It is essential that women are referred to a
physiotherapist specialising in incontinence w21x, but the
CF team should be proactive in seeking out sufferers
and providing support and encouragement with the
treatment.
Appendix A:
We have completed our initial survey about leakage
of urine and found that 68% of females in the unit have
a problem. Some of you asked for help and were referred
to the outpatient physiotherapists for assessment and
advice.
We would be very grateful if you would complete
this questionnaire and comment about the process to
help us with our advice to other patients in the future.
Please read each statement and then indicate which
response is closest to how you feel by ticking one of
the boxes after each statement.
1. Leakage of urine was a big problem to me when
first asked about it.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
2. Leakage of urine greatly interfered with my life
when first asked about it.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
3. I felt happy about being assessed for the problem.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
Comments.
4. After the assessment had been discussed did you
immediately
A Withdraw from assessment h
B Think about assessment h
C Go on for assessment h
If you ticked A or B it would be helpful if you could
tell us why?
If you didn’t then go on for assessment you have
finished this questionnaire and we thank you for your
helpful comments.
If you then went on for assessment please continue.
5. I felt happy with the assessment procedure.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
Comments.
6. After the assessment I understood the action of the
pelvic floor muscle.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
7. The pelvic floor exercises were easy to do.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
If they were difficult please tell us why?
8. The exercises were easy to fit into my treatment
programme at home.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
9. I did the exercises as often as I was advised.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
Comments.
10. I attended the physiotherapy department for fol-
low-up.
All of the time Some of the time Never
h h h
If you didn’t it would be helpful to know why
11. The leakage of urine has improved.
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
Comments
12. The advice and treatment has been worthwhile
Strongly Agree Slightly Slightly Disagree Strongly
agree agree disagree disagree
h h h h h h
If you have any other comments or suggestions as to
how we could improve this service please write them in
the space below.
Thank you for completing the questionnaire.
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